Class ITerminatedD-0638-2022
Drug recall · February 23, 2022
RED MAMMOTH capsules recall
Why: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
RED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5.
- Lots / codes
Lot # DK1027, Exp. 08/01/2023
- Quantity
- 500 cartons
- Company
- Celebrate Today, Brentwood, NY
- Distribution
- Product was distributed nationwide in the USA via Amazon Marketplace
- Initiated
- February 8, 2022 · Voluntary: Firm initiated
- Classified
- February 28, 2022
- Reported
- February 23, 2022
- Ended
- March 29, 2022
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.